Selected research
Market Outlook & Growth Opportunities
Global Technetium-99m Labeled Imaging Agent Market Outlook and Growth Opportunities 2026
Market perspective
The global Technetium-99m Labeled Imaging Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Technetium-99m Labeled Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Technetium-99m Labeled Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Technetium-99m Labeled Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Technetium-99m Labeled Imaging Agent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Technetium-99m Labeled Imaging Agent market include Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Lantheus, SIEMENS, Beijing Zhibo Hi-Tech Biotechnology Co., Ltd., Yantai Dongcheng and China Isotope & Radiation Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Technetium-99m Labeled Imaging Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Technetium-99m Labeled Imaging Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Technetium-99m Labeled Imaging Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Technetium-99m Labeled Imaging Agent market size, projected growth trends, production technologies, key applications, and end-use industries.
Technetium-99m Labeled Imaging Agent Segment by Company
Bracco Imaging
Cardinal Health
Curium Pharma
GE Healthcare
Lantheus
SIEMENS
Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
Yantai Dongcheng
China Isotope & Radiation Corporation
Foshan Rui Diao Pharmaceutical
Technetium-99m Labeled Imaging Agent Segment by Type
99mTc-PYP
99mTc-HMDP
99mTc-DPD
Technetium-99m Labeled Imaging Agent Segment by Application
Bone Imaging
Thyroid Imaging
Brain Imaging
Salivary Gland Imaging
Heterotopic Gastric Mucosal Imaging
Others
Technetium-99m Labeled Imaging Agent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Technetium-99m Labeled Imaging Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Technetium-99m Labeled Imaging Agent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Technetium-99m Labeled Imaging Agent significant trends, drivers, influence factors in global and regions.
6. To analyze Technetium-99m Labeled Imaging Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Technetium-99m Labeled Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Technetium-99m Labeled Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Technetium-99m Labeled Imaging Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Technetium-99m Labeled Imaging Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Technetium-99m Labeled Imaging Agent industry.
Chapter 3: Detailed analysis of Technetium-99m Labeled Imaging Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Technetium-99m Labeled Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Technetium-99m Labeled Imaging Agent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 99mTc-PYP
- 99mTc-HMDP
- 99mTc-DPD
Applications
- Bone Imaging
- Thyroid Imaging
- Brain Imaging
- Salivary Gland Imaging
- Heterotopic Gastric Mucosal Imaging
- Others
Companies covered
- Bracco Imaging
- Cardinal Health
- Curium Pharma
- GE Healthcare
- Lantheus
- SIEMENS
- Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
- Yantai Dongcheng
- China Isotope & Radiation Corporation
- Foshan Rui Diao Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 1.2.2 Global Technetium-99m Labeled Imaging Agent Sales Volume (2021-2032)
- 1.2.3 Global Technetium-99m Labeled Imaging Agent Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Technetium-99m Labeled Imaging Agent Market Dynamics
- 2.1 Technetium-99m Labeled Imaging Agent Industry Trends
- 2.2 Technetium-99m Labeled Imaging Agent Industry Drivers
- 2.3 Technetium-99m Labeled Imaging Agent Industry Opportunities and Challenges
- 2.4 Technetium-99m Labeled Imaging Agent Industry Restraints
3 Technetium-99m Labeled Imaging Agent Market by Company
- 3.1 Global Technetium-99m Labeled Imaging Agent Company Revenue Ranking in 2025
- 3.2 Global Technetium-99m Labeled Imaging Agent Revenue by Company (2021-2026)
- 3.3 Global Technetium-99m Labeled Imaging Agent Sales Volume by Company (2021-2026)
- 3.4 Global Technetium-99m Labeled Imaging Agent Average Price by Company (2021-2026)
- 3.5 Global Technetium-99m Labeled Imaging Agent Company Ranking (2024-2026)
- 3.6 Global Technetium-99m Labeled Imaging Agent Company Manufacturing Base and Headquarters
- 3.7 Global Technetium-99m Labeled Imaging Agent Company Product Type and Application
- 3.8 Global Technetium-99m Labeled Imaging Agent Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Technetium-99m Labeled Imaging Agent Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Technetium-99m Labeled Imaging Agent Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Technetium-99m Labeled Imaging Agent Market by Type
- 4.1 Technetium-99m Labeled Imaging Agent Type Introduction
- 4.1.1 99mTc-PYP
- 4.1.2 99mTc-HMDP
- 4.1.3 99mTc-DPD
- 4.2 Global Technetium-99m Labeled Imaging Agent Sales Volume by Type
- 4.2.1 Global Technetium-99m Labeled Imaging Agent Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Technetium-99m Labeled Imaging Agent Sales Volume by Type (2021-2032)
- 4.2.3 Global Technetium-99m Labeled Imaging Agent Sales Volume Share by Type (2021-2032)
- 4.3 Global Technetium-99m Labeled Imaging Agent Sales Value by Type
- 4.3.1 Global Technetium-99m Labeled Imaging Agent Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Technetium-99m Labeled Imaging Agent Sales Value by Type (2021-2032)
- 4.3.3 Global Technetium-99m Labeled Imaging Agent Sales Value Share by Type (2021-2032)
5 Technetium-99m Labeled Imaging Agent Market by Application
- 5.1 Technetium-99m Labeled Imaging Agent Application Introduction
- 5.1.1 Bone Imaging
- 5.1.2 Thyroid Imaging
- 5.1.3 Brain Imaging
- 5.1.4 Salivary Gland Imaging
- 5.1.5 Heterotopic Gastric Mucosal Imaging
- 5.1.6 Others
- 5.2 Global Technetium-99m Labeled Imaging Agent Sales Volume by Application
- 5.2.1 Global Technetium-99m Labeled Imaging Agent Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Technetium-99m Labeled Imaging Agent Sales Volume by Application (2021-2032)
- 5.2.3 Global Technetium-99m Labeled Imaging Agent Sales Volume Share by Application (2021-2032)
- 5.3 Global Technetium-99m Labeled Imaging Agent Sales Value by Application
- 5.3.1 Global Technetium-99m Labeled Imaging Agent Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Technetium-99m Labeled Imaging Agent Sales Value by Application (2021-2032)
- 5.3.3 Global Technetium-99m Labeled Imaging Agent Sales Value Share by Application (2021-2032)
6 Technetium-99m Labeled Imaging Agent Regional Sales and Value Analysis
- 6.1 Global Technetium-99m Labeled Imaging Agent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Technetium-99m Labeled Imaging Agent Sales by Region (2021-2032)
- 6.2.1 Global Technetium-99m Labeled Imaging Agent Sales by Region: 2021-2026
- 6.2.2 Global Technetium-99m Labeled Imaging Agent Sales by Region (2027-2032)
- 6.3 Global Technetium-99m Labeled Imaging Agent Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Technetium-99m Labeled Imaging Agent Sales Value by Region (2021-2032)
- 6.4.1 Global Technetium-99m Labeled Imaging Agent Sales Value by Region: 2021-2026
- 6.4.2 Global Technetium-99m Labeled Imaging Agent Sales Value by Region (2027-2032)
- 6.5 Global Technetium-99m Labeled Imaging Agent Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 6.6.2 North America Technetium-99m Labeled Imaging Agent Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 6.7.2 Europe Technetium-99m Labeled Imaging Agent Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Technetium-99m Labeled Imaging Agent Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 6.9.2 South America Technetium-99m Labeled Imaging Agent Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Technetium-99m Labeled Imaging Agent Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Technetium-99m Labeled Imaging Agent Sales Value Share by Country, 2025 VS 2032
7 Technetium-99m Labeled Imaging Agent Country-level Sales and Value Analysis
- 7.1 Global Technetium-99m Labeled Imaging Agent Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Technetium-99m Labeled Imaging Agent Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Technetium-99m Labeled Imaging Agent Sales by Country (2021-2032)
- 7.3.1 Global Technetium-99m Labeled Imaging Agent Sales by Country (2021-2026)
- 7.3.2 Global Technetium-99m Labeled Imaging Agent Sales by Country (2027-2032)
- 7.4 Global Technetium-99m Labeled Imaging Agent Sales Value by Country (2021-2032)
- 7.4.1 Global Technetium-99m Labeled Imaging Agent Sales Value by Country (2021-2026)
- 7.4.2 Global Technetium-99m Labeled Imaging Agent Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.9.2 France Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.16.2 China Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.19.2 India Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Technetium-99m Labeled Imaging Agent Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Technetium-99m Labeled Imaging Agent Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Technetium-99m Labeled Imaging Agent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bracco Imaging
- 8.1.1 Bracco Imaging Company Information
- 8.1.2 Bracco Imaging Business Overview
- 8.1.3 Bracco Imaging Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Bracco Imaging Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.1.5 Bracco Imaging Recent Developments
- 8.2 Cardinal Health
- 8.2.1 Cardinal Health Company Information
- 8.2.2 Cardinal Health Business Overview
- 8.2.3 Cardinal Health Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Cardinal Health Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.2.5 Cardinal Health Recent Developments
- 8.3 Curium Pharma
- 8.3.1 Curium Pharma Company Information
- 8.3.2 Curium Pharma Business Overview
- 8.3.3 Curium Pharma Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Curium Pharma Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.3.5 Curium Pharma Recent Developments
- 8.4 GE Healthcare
- 8.4.1 GE Healthcare Company Information
- 8.4.2 GE Healthcare Business Overview
- 8.4.3 GE Healthcare Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.4.4 GE Healthcare Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.4.5 GE Healthcare Recent Developments
- 8.5 Lantheus
- 8.5.1 Lantheus Company Information
- 8.5.2 Lantheus Business Overview
- 8.5.3 Lantheus Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Lantheus Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.5.5 Lantheus Recent Developments
- 8.6 SIEMENS
- 8.6.1 SIEMENS Company Information
- 8.6.2 SIEMENS Business Overview
- 8.6.3 SIEMENS Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.6.4 SIEMENS Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.6.5 SIEMENS Recent Developments
- 8.7 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd.
- 8.7.1 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd. Company Information
- 8.7.2 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd. Business Overview
- 8.7.3 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd. Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd. Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.7.5 Beijing Zhibo Hi-Tech Biotechnology Co., Ltd. Recent Developments
- 8.8 Yantai Dongcheng
- 8.8.1 Yantai Dongcheng Company Information
- 8.8.2 Yantai Dongcheng Business Overview
- 8.8.3 Yantai Dongcheng Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Yantai Dongcheng Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.8.5 Yantai Dongcheng Recent Developments
- 8.9 China Isotope & Radiation Corporation
- 8.9.1 China Isotope & Radiation Corporation Company Information
- 8.9.2 China Isotope & Radiation Corporation Business Overview
- 8.9.3 China Isotope & Radiation Corporation Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.9.4 China Isotope & Radiation Corporation Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.9.5 China Isotope & Radiation Corporation Recent Developments
- 8.10 Foshan Rui Diao Pharmaceutical
- 8.10.1 Foshan Rui Diao Pharmaceutical Company Information
- 8.10.2 Foshan Rui Diao Pharmaceutical Business Overview
- 8.10.3 Foshan Rui Diao Pharmaceutical Technetium-99m Labeled Imaging Agent Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Foshan Rui Diao Pharmaceutical Technetium-99m Labeled Imaging Agent Product Portfolio
- 8.10.5 Foshan Rui Diao Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Technetium-99m Labeled Imaging Agent Value Chain Analysis
- 9.1.1 Technetium-99m Labeled Imaging Agent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Technetium-99m Labeled Imaging Agent Sales Mode & Process
- 9.2 Technetium-99m Labeled Imaging Agent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Technetium-99m Labeled Imaging Agent Distributors
- 9.2.3 Technetium-99m Labeled Imaging Agent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst